Mutant 1,3-propanediol dehydrogenase

Abstract

The present invention relates to mutant 1,3-propanediol dehydrogenase and a novel microorganism that is capable of growing in concentrations of at least 105 g/l 1,3-propanediol, levels normally toxic to wild-type microorganisms. The present invention also provides expression vectors and host cells comprising the mutant 1,3-propanediol dehydrogenase as well as methods for producing 1,3-propanediol comprising the use of cells comprising the mutant 1,3-propanediol dehydrogenase.

Description

FIELD OF THE INVENTION

[0001] The present invention relates to mutant 1,3-propanediol dehydrogenase having an altered Km for 1,3-propanediol. The present invention provides the nucleic acid and amino acid sequence of the mutant form of 1,3-propanediol dehydrogenase. The present invention also provides expression vectors and host cells comprising mutant 1,3-propanediol dehydrogenase.

BACKGROUND OF THE INVENTION

[0002] 1,3-Propanediol is a monomer having potential utility in the production of polyester fibers and the manufacture of polyurethanes and cyclic compounds. The production of 1,3-propanediol has been disclosed in U.S. Pat. No. 5,686,276 issued Nov. 11, 1997 and WO 98/21341. One representative pathway for the production of 1,3-propanediol from glucose can be accomplished by the following series of steps. Glucose is converted in a series of steps by enzymes of the glycolytic pathway to dihydroxyacetone phosphate (DHAP) and 3-phosphoglyceraldehyde (3-PG). Glycerol is then formed by either hydrolysis of DHAP to dihydroxyacetone (DHA) followed by reduction, or reduction of DHAP to glycerol 3-phosphate (G3P) followed by hydrolysis. The hydrolysis step can be catalyzed by any number of cellular phosphatases which are known to be specific or non-specific with respect to their substrates or the activity can be introduced into the host by recombination. The reduction step can be catalyzed by a NAD+ (or NADP+) linked host enzyme or the activity can be introduced into the host by recombination. It is notable that the dha regulon contains a glycerol dehydrogenase (E.C. 1.1.1.6) which catalyzes the reversible reaction of Equation 3.

Glycerol® 3-HP+H2O  (Equation 1)

3-HP+NADH+H+® 1,3-Propanediol+NAD+  (Equation 2)

Glycerol+NAD+® DHA+NADH+H+  (Equation 3)

[0003] Glycerol is converted to 1,3-propanediol via the intermediate 3-hydroxypropionaldehye (3-HP) as has been described in detail above. The intermediate 3-HP is produced from glycerol (Equation 1) by a dehydratase enzyme which can be encoded by the host or can introduced into the host by recombination. This dehydratase can be glycerol dehydratase (E.C. 4.2.1.30), diol dehydratase (E.C. 4.2.1.28), or any other enzyme able to catalyze this transformation. Glycerol dehydratase is encoded by the dha regulon. 1,3-Propanediol is produced from 3-HP (Equation 2) by a NAD+-(or NADP+) linked host enzyme or the activity can introduced into the host by recombination. This final reaction in the production of 1,3-propanediol can be catalyzed by 1,3-propanediol dehydrogenase (E.C. 1.1.1.202) or other alcohol dehydrogenases.

[0004] In Klebsiella pneumoniae and Citrobacter freundii, the genes encoding the functionally linked activities of glycerol dehydratase (dhaB), 1,3-propanediol oxidoreductase (dhaT), glycerol dehydrogenase (dhaD), and dihydroxyacetone kinase (dhaK) are encompassed by the dha regulon. The dha regulons from Citrobacter and Klebsiella have been expressed in Escherichia coli and have been shown to convert glycerol to 1,3-propanediol.

[0005] Nucleic acid and amino acid sequences for a 1,3-propanediol dehydrogenase that have been disclosed in the art, including Klebsiella pneumoniae GenBank accession # U30903 (Williard, 1994, “Investigation of the Klebsiella pneumoniae 1,3-propanediol pathway: Characterization and expression of glycerol dehydratase and 1,3-propanediol oxidoreductase” Thesis Chemical Engineering, University of Wisconsin-Madison); Citrobacter freundii GenBank accession # U09771 (Daniel, R. et al., 1995, Purification of 1,3-propanediol dehydrogenase from Citrobacter freundii: cloning, sequencing, and overexpression of the corresponding gene in Escherichia coli. J. Bacteriol. 177:2151-2156); and Clostridium pasteurianum GenBank accession # AF006034 (Luers,F. et al., 1997, Glycerol conversion to 1,3-propanediol by Clostridium pasteurianum: cloning and expression of the gene encoding 1,3-propanediol dehydrogenase. FEMS Microbiol. Lett. 154:337-345).

SUMMARY OF THE INVENTION

[0006] The present invention relates to the discovery of a mutant form of 1,3-propanediol dehydrogenase (PDD) isolated from a derivative of E.blattae capable of growth in the presence of at least 105 g/l 1,3-propanediol, levels normally toxic to wild-type E.blattae. The present invention is therefore based in part upon the discovery that the mutant form of PDD is associated with E.blattae's resistance to normally toxic levels of 1,3-propanediol. The present invention is also based in part upon the finding that this mutant PDD has an altered Km for 1,3-propanediol and NAD.

[0007] Accordingly, the present invention provides a mutant PDD having a Km for 1,3-propanediol that is increased over the wild-type PDD Km for 1,3-propanediol. In one embodiment, the Km of the mutant PDD is about 3 times the Km of wild-type PDD for 1,3-propanediol. In another embodiment, the mutant PDD has a Km of about 80 mM for 1,3-propanediol. In a further embodiment, the mutant PDD is obtainable from E.blattae ATCC accession number PTA-92.

[0008] In yet another embodiment of the present invention, the mutant PDD comprises a mutation corresponding to residue His105 to Leu in E.blatte PDD as shown in FIG. 3. In an additional embodiment, the mutant PDD comprises the amino acid shown in SEQ ID NO:2 and is encoded by nucleic acid having the sequence as shown in SEQ ID NO:1.

[0009] The present invention also provides expression vectors and host cells comprising the isolated nucleic acid having the sequence as shown in SEQ ID NO:1. In one embodiment, the host cell includes Citrobacter, Enterobacter, Clostridium, Klebsiella, Aerobacter, Lactobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobacter, Escherichia, Salmonella, Bacillus, Streptomyces and Pseudomonas.

[0010] In an additional aspect, the present invention relates to methods for producing 1,3-propanediol comprising the use of a microorganism comprising mutant PDD.

BRIEF DESCRIPTION OF THE DRAWINGS

[0011] FIG. 1 provides the nucleic acid sequence (SEQ ID NO:1) for the mutant 1,3-propanediol dehydrogenase (PDD).

[0012] FIG. 2 provides the amino acid sequence (SEQ ID NO:2) for the mutant 1,3-propanediol dehydrogenase (PDD).

[0013] FIG. 3 provides an amino acid alignment of PDDs from various microorganisms. Eb_GEBT represents the ATCC deposited E.blattae mutant PDD, Eb—429T and Eb—907T are wild-type E.blattae (ATCC accession number 33429); Kpn is Klebsiella pneumoniae (GenBank accession # U30903); Cfu is Citrobacter freundii (GenBank accession number U09771) and Cpast is Clostridium pasteurianum (GenBank accession number AF006034).

DESCRIPTION OF THE MICROORGANISM DEPOSITS MADE UNDER THE BUDAPEST TREATY

[0014] Applicants have made the following biological deposits under the terms of the Budapest Treaty on the International Recognition of the Deposit of Micro-organisms for the Purposes of Patent Procedure:

Depositor Identification	International Depository
Reference	Designation	Date of Deposit
Escherichia blattae	PTA-92	May 19, 1999
33429 derivative

DETAILED DESCRIPTION

Definitions

[0015] The terms “1,3-propanediol dehydrogenase” or “PDD” (also known in the art as “oxidoreductase”) refer to the polypeptide(s) responsible for an enzyme activity that is capable of catalyzing the reduction of 3-hydroxypropionaldehyde to 1,3-propanediol. 1,3-Propanediol dehydrogenase includes, for example, the polypeptide encoded by the dhaT gene. The present invention encompasses 3-propanediol dehydrogenase from any source including, but not limited to E.blatte, K.pneumoniae, C.freundii, C.pasteurianum.

[0016] As used herein, the term “mutant” or “mutation” refers to any genetic change that occurs in the nucleic acid of a microorganism and may or may not reflect a phenotypic change within the microorganism. A mutation may comprise a single base pair change, deletion or insertion; a mutation may comprise a change, deletion or insertion in a large number of base pairs; a mutation may also comprise a change in a large region of DNA, such as through duplication or inversion. The amino acid sequence of a mutant 1,3-propanediol dehydrogenase can be derived from a precursor 1,3-propanediol dehydrogenase by the substitution, deletion or insertion of one or more amino acids of the naturally occurring 1,3-propanediol dehydrogenase. Methods for modifying genes (e.g., through site-directed oligonucleotide mutagenesis) have been described in the art.

[0017] The phrase “corresponding to” as used herein refers to the amino acid relatedness among 1,3-propanediol dehydrogenases as exemplified by FIG. 3. Specific residues discussed herein refer to an amino acid residue number which references the number assigned to the E.blatte GEB PDD shown in FIG. 3. The mutation of His to Leu is shown at residue 105 in FIG. 3. FIG. 3 illustrates that 1,3-propanediol dehydrogenases from a variety of microbial sources can be aligned using the algorithm CLUSTALW. The invention is not limited to the mutation of the E.blattae PDD shown in FIGS. 1 and 2, or the E.blattae deposited with the ATCC and having accession number PTA-92 but encompasses all PDDs containing amino acid residues at positions which are equivalent to the particular identified residue in E.blattae. A residue is equivalent if it is either homologous (i.e., corresponds in position for either the primary or tertiary structure) or analogous to a specific residue or portion of that residue in E.blattae PDD (i.e., having the same or similar functional capacity to combine, react, or interact chemically or structurally).

[0018] In order to establish homology to primary structure, the amino acid sequence of a PDD is directly compared to the E.blattae PDD primary sequence (shown in FIG. 2) and particularly to a set of residues known to be invariant to all PDDs for which sequences are known (see, e.g., FIG. 3). The present invention encompasses the equivalent residue change in all sources of 1,3-propanediol dehydrogenase as long as the mutant form is able to alter the Km of the activity for 1,3-propanediol. In a preferred embodiment, the Km of the mutant form is increased for 1,3-propanediol. The nucleic acid sequence of SEQ ID NO:1 was obtained via PCR techniques. Such techniques are often characterized by inadvertent PCR generated sequence error. Therefore, the present invention also encompasses the 1,3-propanediol dehydrogenase of E.blattae having ATCC accession number PTA-92 and corresponding mutations in other microbial sources of the 1,3-propanediol dehydrogenases.

[0019] The term “Km” refers to affinity of the enzyme for the substrate. A high Km reflects a low affinity; a low Km reflects a high affinity.

[0020] The terms “carbon substrate” and “carbon source” refer to a carbon source capable of being metabolized by host organisms of the present invention and particularly carbon sources selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, and one-carbon substrates or mixtures thereof.

[0021] The terms “host cell” or “host organism” refer to a microorganism capable of receiving foreign or heterologous genes and of expressing those genes to produce an active gene product.

[0022] As used herein, “nucleic acid” refers to a nucleotide or polynucleotide sequence, and fragments or portions thereof, and to DNA or RNA of genomic or synthetic origin which may be double-stranded or single-stranded, whether representing the sense or antisense strand. The terms “native” and “wild-type” refer to a gene as found in nature with its own regulatory sequences. As used herein “amino acid” refers to peptide or protein sequences or portions thereof.

[0023] The term “expression” refers to the transcription and translation to gene product from a gene coding for the sequence of the gene product.

[0024] The terms “plasmid”, “vector”, and “cassefte” refer to an extra chromosomal element often carrying genes which are not part of the central metabolism of the cell, and usually in the form of circular double-stranded DNA molecules. Such elements may be autonomously replicating sequences, genome integrating sequences, phage or nucleotide sequences, linear or circular, of a single- or double-stranded DNA or RNA, derived from any source, in which a number of nucleotide sequences have been joined or recombined into a unique construction which is capable of introducing a promoter fragment and DNA sequence for a selected gene product along with appropriate 3′ untranslated sequence into a cell. “Transformation cassette” refers to a specific vector containing a foreign gene and having elements in addition to the foreign gene that facilitate transformation of a particular host cell. “Expression cassette” refers to a specific vector containing a foreign gene and having elements in addition to the foreign gene that allow for enhanced expression of that gene in a foreign host.

[0025] The terms “isolated” or “purified” as used herein refer to a nucleic acid or amino acid that is removed from at least one component with which it is naturally associated.

DETAILED DESCRIPTION OF THE INVENTION

[0026] The present invention relates to mutant 1,3-propanediol dehydrogenase (PDD) characterized by having an increased Km for 1,3 propanediol.

[0027] I. PDD Sequences

[0028] Polynucleotide sequence as shown in SEQ ID NO:1 encodes the 1,3-propanediol dehydrogenase (SEQ ID NO:2) having the mutation of His to Leu at residue 105 as shown in FIG. 3. As will be understood by the skilled artisan, due to the degeneracy of the genetic code, a variety of polynucleotides can encode SEQ ID NO:2. The present invention encompasses all such polynucleotides. The present invention encompasses nucleic acid encoding PDD comprising a mutation corresponding to E.blatte residue His 105 to Leu as shown in FIG. 3. The nucleic acid and amino acid sequence for PDD from K.pneumoniae is given in GenBank accession number U30903; PDD from C. freundii is given in GenBank accession number U09771; for PDD from C.pasteurianum is given in GenBank accession number AF00034. The present invention also encompasses mutant PDD obtainable from E.blattae having ATCC accession number PTA-92.

[0029] Methods of obtaining desired genes from a microbial genome are common and well known in the art of molecular biology. For example, if the sequence of the gene is known, suitable genomic libraries may be created by restriction endonuclease digestion and may be screened with probes complementary to the desired gene sequence. Once the sequence is isolated, the DNA may be amplified using standard primer directed amplification methods such as polymerase chain reaction (PCR) (U.S. Pat. No. 4,683,202) to obtain amounts of DNA suitable for transformation using appropriate vectors.

[0030] Alternatively, methods of using cosmid vectors for the transformation of suitable bacterial hosts are well described in Sambrook et al., Molecular Cloning: A Laboratory Manual, Second Edition (1989) Cold Spring Harbor Laboratory Press, Cold Spring Harbon, N.Y. (1989).

[0031] Methods of making mutations in PDD genes are known to the skilled artisan and include for example site-directed mutagenesis, procedures described in United States patent U.S. Pat. No. 4,760,025 issued Jul. 26, 1988.

[0032] Vectors and Expression Cassettes

[0033] The present invention provides a variety of vectors and transformation and expression cassettes suitable for the cloning, transformation and expression of mutant PDD as well as other proteins associated with 1,3-propanediol production into a suitable host cell. Suitable vectors will be those which are compatible with the bacterium employed. Suitable vectors can be derived, for example, from a bacteria, a virus (such as bacteriophage T7 or a M-13 derived phage), a cosmid, a yeast or a plant. Protocols for obtaining and using such vectors are known to those in the art. (Sambrook et al., Molecular Cloning: A Laboratory Manual—volumes 1,2,3 (Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y., (1989)).

[0034] Typically, the vector or cassette contains sequences directing transcription and translation of the relevant gene, a selectable marker, and sequences allowing autonomous replication or chromosomal integration. Suitable vectors comprise a region 5′ of the gene which harbors transcriptional initiation controls and a region 3′ of the DNA fragment which controls transcriptional termination. It is most preferred when both control regions are derived from genes homologous to the transformed host cell although it is to be understood that such control regions need not be derived from the genes native to the specific species chosen as a production host.

[0035] Initiation control regions or promoters, which are useful to drive expression of PDD in the desired host cell, are numerous and familiar to those skilled in the art. Virtually any promoter capable of driving these genes is suitable for the present invention including but not limited to CYC1, HIS3, GAL1, GAL10, ADH1, PGK, PHO5, GAPDH, ADC1, TRP1, URA3, LEU2, ENO, TPI (useful for expression in Saccharomyces); AOX1 (useful for expression in Pichia); and lac, trp, IPL, IPR, T7, tac, and trc (useful for expression in E. coli).

[0036] Termination control regions may also be derived from various genes native to the preferred hosts. Optionally, a termination site may be unnecessary, however, it is most preferred if included.

[0037] For effective expression of the instant enzymes, DNA encoding the enzymes are linked operably through initiation codons to selected expression control regions such that expression results in the formation of the appropriate messenger RNA.

[0038] Transformation of Suitable Hosts and Expression of PDD

[0039] Once suitable cassettes are constructed they are used to transform appropriate host cells. Introduction of the cassette containing mutant 1,3-propanediol dehydrogenase, either separately or together with other proteins necessary for the production of 1,3-propanediol, into the host cell may be accomplished by known procedures such as by transformation (e.g., using calcium-permeabilized cells, electroporation) or by transfection using a recombinant phage virus. (Sambrook et al., supra.).

[0040] Host Cells

[0041] Suitable host cells for the recombinant production of 1,3-propanediol may be either prokaryotic or eukaryotic and will be limited only by the host cell ability to express active enzymes. Preferred hosts will be those typically useful for production of glycerol or 1,3-propanediol such as Citrobacter, Enterobacter, Clostridium, Klebsiella, Aerobacter, Lactobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobacter, Escherichia, Salmonella, Bacillus, Streptomyces and Pseudomonas. Most preferred in the present invention are E. coli, Klebsiella species and Saccharomyces species.

[0042] Media and Carbon Substrates

[0043] Fermentation media in the present invention must contain suitable carbon substrates. Suitable substrates may include but are not limited to monosaccharides such as glucose and fructose, oligosaccharides such as lactose or sucrose, polysaccharides such as starch or cellulose, or mixtures thereof, and unpurified mixtures from renewable feedstocks such as cheese whey permeate, cornsteep liquor, sugar beet molasses, and barley malt. Additionally, the carbon substrate may also be one-carbon substrates such as carbon dioxide, or methanol for which metabolic conversion into key biochemical intermediates has been demonstrated.

[0044] Preferred carbon substrates are monosaccharides, oligosaccharides, polysaccharides, and one-carbon substrates. More preferred are sugars such as glucose, fructose, sucrose and single carbon substrates such as methanol and carbon dioxide. Most preferred is glucose.

[0045] In addition to an appropriate carbon source, fermentation media must contain suitable minerals, salts, cofactors, buffers and other components, known to those skilled in the art, suitable for the growth of the cultures and promotion of the enzymatic pathway necessary for glycerol production. Particular attention is given to Co(II) salts and/or vitamin B12 or precursors thereof.

[0046] Culture Conditions

[0047] Typically, cells are grown at 30° C. in appropriate media. Preferred growth media in the present invention are common commercially prepared media such as Luria Bertani (LB) broth, Sabouraud Dextrose (SD) broth or Yeast Malt Extract (YM) broth. Other defined or synthetic growth media may also be used and the appropriate medium for growth of the particular microorganism will be known by someone skilled in the art of microbiology or fermentation science. The use of agents known to modulate catabolite repression directly or indirectly, e.g., cyclic adenosine 2′:3′-monophosphate or cyclic adenosine 2′:5′-monophosphate, may also be incorporated into the reaction media. Similarly, the use of agents known to modulate enzymatic activities (e.g., sulphites, bisulphites and alkalis) that lead to enhancement of glycerol production may be used in conjunction with or as an alternative to genetic manipulations.

[0048] Suitable pH ranges for the fermentation are between pH 5.0 to pH 9.0, where pH 6.0 to pH 8.0 is preferred as range for the initial condition.

[0049] Reactions may be performed under aerobic or anaerobic conditions where anaerobic or microaerobic conditions are preferred.

[0050] The manner and method of carrying out the present invention may be more fully understood by those of skill in the art by reference to the following examples, which examples are not intended in any manner to limit the scope of the present invention or of the claims directed thereto.

EXAMPLES

[0051] Example 1 describes the kinetic changes associated with the mutant PDD shown in SEQ ID NO:2.

[0052] Materials and Methods

[0053] Strains—Wild type ATCC 33429, E.blattae comprising the mutant PDD ATCC accession number PTA-92.

[0054] Growth—Cells were grown in a complex medium at 30C 500 ml in a 2800 ml fernbach with shaking at 225 rpm for 20 hr. The medium consists of KH2PO4, 5.4 g/L; (NH4)2SO4, 1.2 g/L; MgSO47H2O, 0.4 g/L; yeast extract, 2.0 g/L; tryptone, 2.0 g/L; and glycerol, 9.2 g/L in tap water. The pH was adjusted to 7.1 with KOH before autoclaving (Honda, et al., 1980, J. Bacteriol, 143:1458-1465).

[0055] Extract prep—Cells were harvested by centrifugation with care to avoid anaerobic conditions. Pellets were resuspended in 100 mM Tricine pH 8.2 containing 50 mM KCl and 1 mM DTT. Cells were disrupted by passage through a French pressure cell. Crude extracts were clarified by centrifugation at 20K×g for 20 min followed by 100K×g for 1 hr to yield the high speed supernatant (HSS) fraction.

[0056] Assays—the assay for PDD was performed as described by Johnson, E. A. et al., 1987, J. Bacteriol. 169:2050-2054.

[0057] Partial purification of PDD—HSS was separated on a 16×100 Poros 20HQ column. The buffers were A, 50 mM HEPES, pH 7.4 containing 100 uM MnCl and B, A buffer containing 500 mM KCl. The column was loaded and developed at 10 ml/min. The gradient was 10 CV wash, a linear gradient to 70% B in 10 CV, and 1 CV to 100% B. The activity was detected in the very early fractions of the gradient. Pooled column fractions of the 33429 strain were used as collected for assays after the addition of additional of DTT to 1 mM. The active fractions from strain GEB031 were pooled and concentrated on a PM30 membrane and used as concentrated after the addition of additional 1 mM DTT.

	Strain	GD (U/mg)	PDD (U/mg)	Ratio GD/PDD
	33429	0.64	0.22	2.9
	GEB031	0.79	0.08	9.9

[0058] PDD Kinetics—The results are shown below.

	Strain	Km (mM Propanediol)	Km (uM NAD)
	33429	28	57

[0059] Example 2: Cloning and sequencing the 1,3-propanediol dehydrogenase genes (dhaT) from E. blattae.

[0060] The dhaT genes were amplified by PCR from genomic DNA from E. blattae as template DNA using synthetic primers (primer 1 and primer 2) based on the K. pneumoniae dhaT sequence and incorporating an XbaI site at the 5′ end and a BamHI site at the 3′ end. The product was subcloned into pCR-Blunt II-TOPO (Invitrogen). The cloning dhaT were then sequenced was standard techniques.

[0061] The results of the DNA sequencing are given in SEQ ID NO:1 and SEQ ID NO:2.

Primer 1
5′ TCTGATACGGGATCCTCAGAATGCCTGGCGGAAAAT3′
Primer 2
5′ GCGCCGTCTAGAATTATGAGCTATCGTATGTTTGATTATCTG3′

[0062] As will be readily understood by the skilled artisan, nucleic acid sequence generated via PCR methods may comprise inadvertent errors. The present invention also encompasses nucleic acid encoding PDD obtainable from E.blattae having ATCC accession number PTA-92.

[0063] All references cited herein, including patents, patent applications, sequences and publications are hereby incorporated in their entirety by reference.

Claims

1. A mutant 1,3-propanediol dehydrogenase having an increased Km for 1,3-propanediol over the corresponding wild-type 1,3-propanediol dehydrogenase Km for 1,3-propanediol.

2. The mutant 1,3-propanediol dehydrogenase of claim 1 wherein the increased Km is about three times the wild-type Km.

3. The mutant 1,3-propanediol dehydrogenase of claim 1 having a Km of about 80 mM for 1,3-propanediol.

4. The mutant 1,3-propanediol dehydrogenase of claim 1 which is obtainable from E.blattae having ATCC accession number PTA-92.

5. The mutant 1,3-propanediol dehydrogenase of claim 1 comprising a mutation corresponding to residue His105 to Leu in E.blatte as shown in FIG. 3.

6. The mutant 1,3 propanediol dehydrogenase of claim 1 comprising the amino acid having the sequence as shown in SEQ ID NO:2.

7. An isolated nucleic acid encoding mutant 1,3-propanediol dehydrogenase having the sequence as shown in SEQ ID NO:2.

8. The isolated nucleic acid of claim 7 having the sequence as shown in SEQ ID No:1:

9. An expression vector comprising the isolated nucleic acid of claim 7.

10. A host cell comprising the expression vector of claim 9.

11. The host cell of claim 10 that includes Citrobacter, Enterobacter, Clostridium, Klebsiella, Aerobacter, Lactobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobacter, Escherichia, Salmonella, Bacillus, Streptomyces and Pseudomonas.

12. The host cell of claim 10 wherein said mutant 1,3-propanediol dehydrogenase comprises a mutation corresponding to residue His105 to Leu in E.blatte shown in FIG. 3.

13. The host cell of claim 12 wherein said mutant 1,3-propanediol dehydrogenase has the amino acid sequence as shown in SEQ ID NO:2.

14. A method for making 1,3-propanediol in a microorganism comprising the steps of i. obtaining a microorganism comprising a mutant 1,3-propanediol dehydrogenase (PDD) having an increased Km for 1,3-propanediol over the corresponding wild-type PDD, said microorganism comprising at least one gene capable of expressing a dehydratase activity, and ii. contacting said microorganism with a carbon substrate.

15. The method of claim 14 wherein said mutant 1,3-propanediol dehydrogenase comprises a mutation corresponding to residue His105 to Leu in E.blatte shown in FIG. 3.

16. The method of claim 15 wherein said mutant 1,3-propanediol comprises the amino acid sequence as shown in SEQ ID NO:2.

17. The method of claim 14 wherein said mutant 1,3-propanediol dehydrogenase is obtainable from E.blattae having ATCC accession number PTA-92.

18. The method of claim 14 wherein said microorganism includes Citrobacter, Enterobacter, Clostridium, Klebsiella, Aerobacter, Lactobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Tolulopsis, Methylobacter, Escherichia, Salmonella, Bacillus, Streptomyces and Pseudomonas.

19. An isolated microorganism having ATCC accession number PTA-92.